The DOI matches its Crossref record; 234 of the 234 references it cites were found in a registry or an index.
Heme Oxygenase-1: An Anti-Inflammatory Effector in Cardiovascular, Lung, and Related Metabolic Disorders
Open accessAbstract
The heme oxygenase (HO) enzyme system catabolizes heme to carbon monoxide (CO), ferrous iron, and biliverdin-IXα (BV), which is reduced to bilirubin-IXα (BR) by biliverdin reductase (BVR). HO activity is represented by two distinct isozymes, the inducible form, HO-1, and a constitutive form, HO-2, encoded by distinct genes (HMOX1, HMOX2, respectively). HO-1 responds to transcriptional activation in response to a wide variety of chemical and physical stimuli, including its natural substrate heme, oxidants, and phytochemical antioxidants. The expression of HO-1 is regulated by NF-E2-related factor-2 and counter-regulated by Bach-1, in a heme-sensitive manner. Additionally, HMOX1 promoter polymorphisms have been associated with human disease. The induction of HO-1 can confer protection in inflammatory conditions through removal of heme, a pro-oxidant and potential catalyst of lipid peroxidation, whereas iron released from HO activity may trigger ferritin synthesis or ferroptosis. The production of heme-derived reaction products (i.e., BV, BR) may contribute to HO-dependent cytoprotection via antioxidant and immunomodulatory effects. Additionally, BVR and BR have newly recognized roles in lipid regulation. CO may alter mitochondrial function leading to modulation of downstream signaling pathways that culminate in anti-apoptotic, anti-inflammatory, anti-proliferative and immunomodulatory effects. This review will present evidence for beneficial effects of HO-1 and its reaction products in human diseases, including cardiovascular disease (CVD), metabolic conditions, including diabetes and obesity, as well as acute and chronic diseases of the liver, kidney, or lung. Strategies targeting the HO-1 pathway, including genetic or chemical modulation of HO-1 expression, or application of BR, CO gas, or CO donor compounds show therapeutic potential in inflammatory conditions, including organ ischemia/reperfusion injury. Evidence from human studies indicate that HO-1 expression may represent a biomarker of oxidative stress in various clinical conditions, while increases in serum BR levels have been correlated inversely to risk of CVD and metabolic disease. Ongoing human clinical trials investigate the potential of CO as a therapeutic in human disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–234 of 234
Heme oxygenase-2 is post-translationally regulated by heme occupancy in the catalytic site
Liu, L., Dumbrepatil, A. B., Fleischhacker, A. S., Marsh, E. N. G., & Ragsdale, S. W. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014919 · Cited by 30
Chen, W., Tumanov, S., Fazakerley, D. J., Cantley, J., James, D. E., Dunn, L., Shaik, T., Suarna, C., & Stocker, R. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102152 · Cited by 30
Increased susceptibility of cystic fibrosis airway epithelial cells to ferroptosis
Maniam, P., Essilfie, A., Kalimutho, M., Ling, D., Frazer, D. M., Phipps, S., Anderson, G. J., & Reid, D. W. (2021) · Biological Research · doi:10.1186/s40659-021-00361-3 · Cited by 30
Preservation solution supplemented with biliverdin prevents lung cold ischaemia/reperfusion injury
Sugimoto, R., Tanaka, Y., Noda, K., Kawamura, T., Toyoda, Y., Billiar, T. R., McCurry, K. R., & Nakao, A. (2012) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezs298 · Cited by 29
Heme in Cardiovascular Diseases: A Ubiquitous Dangerous Molecule Worthy of Vigilance
Guo, Y., Zhao, H., Lin, Z., Ye, T., Xu, D., & Zeng, Q. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.781839 · Cited by 29
Fleischhacker, A. S., Carter, E. L., & Ragsdale, S. W. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7368 · Cited by 27
Tsuburai, T., Kaneko, T., Nagashima, Y., Ueda, A., Tagawa, A., Shinohara, T., & Ishigatsubo, Y. (2004) · Human Gene Therapy · doi:10.1089/104303404322886129 · Cited by 25
Zhou, H., Ying, X., Liu, Y., Ye, S., Yan, J., & Li, Y. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13028 · Cited by 25
Immunomodulatory Effects of Heme Oxygenase-1 in Kidney Disease
Li, Y., Ma, K., Han, Z., Chi, M., Sai, X., Zhu, P., Ding, Z., Song, L., & Liu, C. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.708453 · Cited by 24
Dugbartey, G. J. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114752 · Cited by 24
Maines, M. D. (2010) · Current Drug Targets · doi:10.2174/1389450111009011586 · Cited by 23
Heme oxygenase-1 polymorphism associated with severity of chronic obstructive pulmonary disease
Fu, W., Zhi-huan, Z. H. A. O., Fang, L., Sun, C., Lin, L. I. U., Zhang, J., Zhang, Y., & Dai, L.-M. (2007) · Chinese Medical Journal · doi:10.1097/00029330-200701010-00003 · Cited by 23
Dual effect of hemin on renal ischemia-reperfusion injury
Rossi, M., Delbauve, S., Wespes, E., Roumeguère, T., Léo, O., Flamand, V., Moine, A. L., & Hougardy, J. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.046 · Cited by 23
Fleischhacker, A. S., Gunawan, A. L., Kochert, B. A., Liu, L., Wales, T. E., Borowy, M. C., Engen, J. R., & Ragsdale, S. W. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.012803 · Cited by 23
Sasson, A., Kristoferson, E., Batista, R. O., McClung, J. A., Abraham, N. G., & Peterson, S. J. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108679 · Cited by 23
Biliverdin reductase as a target in drug research and development: Facts and hypotheses
Mancuso, C. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.06.034 · Cited by 22
HO-1 and Heme: G-Quadruplex Interaction Choreograph DNA Damage Responses and Cancer Growth
Canesin, G., Muralidharan, A. M., Swanson, K. D., & Wegiel, B. (2021) · Cells · doi:10.3390/cells10071801 · Cited by 22
Regulation of protein function and degradation by heme, heme responsive motifs, and CO
Fleischhacker, A. S., Sarkar, A., Liu, L., & Ragsdale, S. W. (2021) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2021.1961674 · Cited by 22
Yao, H., Peterson, A. L., Li, J., Xu, H., & Dennery, P. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197123 · Cited by 21
Ceccarelli, V., Barchetta, I., Cimini, F. A., Bertoccini, L., Chiappetta, C., Capoccia, D., Carletti, R., Cristofano, C. D., Silecchia, G., Fontana, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239091 · Cited by 19
Nagasawa, R., Hara, Y., Murohashi, K., Aoki, A., Kobayashi, N., Takagi, S., Hashimoto, S., Kawana, A., & Kaneko, T. (2020) · BMC Pulmonary Medicine · doi:10.1186/s12890-020-01341-1 · Cited by 17
Du, J., Ren, W., Zhang, Q., Fu, N., Han, F., Cui, P., Li, W., Kong, L., Zhao, S., Wang, R., et al. (2020) · BioMed Research International · doi:10.1155/2020/4910601 · Cited by 16
Defective BACH1/HO-1 regulatory circuits in cystic fibrosis bronchial epithelial cells
Chillappagari, S., Garapati, V., Mahavadi, P., Naehrlich, L., Schmeck, B., Schmitz, M. L., & Günther, A. (2020) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2020.05.006 · Cited by 16
Wu, G., Martin, E., Berka, V., Liu, W., Garcin, E. D., & Tsai, A. (2020) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2020.111267 · Cited by 16
Tripathi, R., Yang, X., Ryter, S. W., & Wang, B. (2021) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026621666211116090917 · Cited by 15
Self-citationCimini, F. A., Barchetta, I., Zuliani, I., Pagnotta, S. E., Bertoccini, L., Dule, S., Zampieri, M., Reale, A., Baroni, M. G., Cavallo, M. G., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119913 · Cited by 13
Horio, T., Morishita, E., Mizuno, S., Uchino, K., Hanamura, I., Espinoza, J. L., Morishima, Y., Kodera, Y., Onizuka, M., Kashiwase, K., et al. (2020) · Cancers · doi:10.3390/cancers12020424 · Cited by 12
Pelullo, M., Savi, D., Quattrucci, S., Cimino, G. G., Pizzuti, A., Screpanti, I., Talora, C., & Cialfi, S. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10017 · Cited by 12
Cerrito, M. G., Scagliarini, A., Froio, A., Liloia, A., Busnelli, M., Giovannoni, R., Otterbein, L. E., Mainetti, L., Villa, M., Bach, F. H., et al. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.1204 · Cited by 11
Liang, K., Lee, W., Lee, W.-L., Wu, J.-P., Lee, I., Wang, J., & Sheu, W. H. (2021) · Heart and Vessels · doi:10.1007/s00380-020-01733-7 · Cited by 11
Recipient hyperbilirubinaemia protects cardiac graft in rat heterotopic heart transplantation
Lee, S., Yamada, T., Osako, T., Stolz, D. B., Abe, M., McCurry, K. R., Murase, N., Kotani, J., & Nakao, A. (2013) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezt402 · Cited by 9
Heme Oxygenase-1 in Patients With Interstitial Lung Disease: A Review of the Clinical Evidence
Hara, Y., Nakashima, K., Nagasawa, R., Murohashi, K., Tagami, Y., Aoki, A., Okudela, K., & Kaneko, T. (2021) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2021.02.009 · Cited by 9
Liang, K.-W., Lee, W.-J., Lee, W.-L., Wu, J.-P., & Sheu, W. H. (2021) · Biomarkers · doi:10.1080/1354750x.2021.1992650 · Cited by 9
The Protective Role of the Heme Catabolic Pathway in Hepatic Disorders
Vítek, L. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0080 · Cited by 8
Cited by
Wang, L., & He, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.967193 · Cited by 324
Oxidative Stress in Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2022) · Antioxidants · doi:10.3390/antiox11050965 · Cited by 281
Yanagisawa, H., Maeda, H., Noguchi, I., Tanaka, M., Wada, N., Nagasaki, T., Kobayashi, K., Kanazawa, G., Taguchi, K., Chuang, V. T. G., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103314 · Cited by 10
Metadata
- Authors
- Ryter, S. W.
- Venue
- Antioxidants
- Publisher
- MDPI AG
- Published
- 2022-03-15
- Volume
- 11
- Issue
- 3
- Pages
- 555
- ISSN
- 2076-3921 (ISSN-L)
- OpenAlex
- W4220849812
- Cited by
- 271
- References
- 234
- FWCI
- 15.05
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.